Skip to content
★ Sign in to follow
PD

Paul D. Kessler

Vaxart, Inc.
Total declarations
41
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (38 ops.)
€264k

Latest filing published 09 Apr 2012 for Vaxart, Inc., €7,514.

Insider track record

Disclosed buys
0
Disclosed sells
38
Signal history

No signal scores available.

Paul D. Kessler: trading record in brief

Paul D. Kessler is a declared insider of Vaxart, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 5 March 2008 to 5 April 2012, the count stands at 41 filings.

The open-market record consists of 38 sales worth €264k, with no purchase. The rest of the record consists of 3 share grants. So far in 2012, the count stands at no purchases and 1 sale.

The latest filing, published on 9 April 2012, reports an open-market sale of €7,514 in Vaxart, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Paul D. Kessler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations40 total
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    9,817 USD0SEC
    5,167 shares@ US$1.90Common StockSEC:0001491877-12-000022:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    41,475 USD0SEC
    7,500 shares@ US$5.53Common StockSEC:0001455244-11-000025:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    26,720 USD0SEC
    4,876 shares@ US$5.48Common StockSEC:0001455244-11-000025:1
  • ◆
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    0SEC
    36,000 shares0Common StockSEC:0001455244-11-000015:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    49,513 USD0SEC
    8,596 shares@ US$5.76Common StockSEC:0001455244-11-000015:1
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    16,865 USD0SEC
    2,985 shares@ US$5.65Common StockSEC:0001455244-11-000002:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    1,704 USD0SEC
    300 shares@ US$5.68Common StockSEC:0001491877-10-000002:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    285 USD0SEC
    50 shares@ US$5.69Common StockSEC:0001491877-10-000002:1
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    4,837 USD0SEC
    850 shares@ US$5.69Common StockSEC:0001491877-10-000002:2
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    5,700 USD0SEC
    1,000 shares@ US$5.70Common StockSEC:0001491877-10-000002:3
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    18,269 USD0SEC
    3,205 shares@ US$5.70Common StockSEC:0001491877-10-000002:4
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    3,997 USD0SEC
    700 shares@ US$5.71Common StockSEC:0001491877-10-000002:5
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    20,510 USD0SEC
    3,592 shares@ US$5.71Common StockSEC:0001491877-10-000002:6
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    572 USD0SEC
    100 shares@ US$5.72Common StockSEC:0001491877-10-000002:7
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    10,868 USD0SEC
    1,900 shares@ US$5.72Common StockSEC:0001491877-10-000002:8
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    573 USD0SEC
    100 shares@ US$5.73Common StockSEC:0001491877-10-000002:9
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    8,022 USD0SEC
    1,400 shares@ US$5.73Common StockSEC:0001491877-10-000002:10
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    5,757 USD0SEC
    1,003 shares@ US$5.74Common StockSEC:0001491877-10-000002:11
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    3,450 USD0SEC
    600 shares@ US$5.75Common StockSEC:0001491877-10-000002:12
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    1,152 USD0SEC
    200 shares@ US$5.76Common StockSEC:0001491877-10-000002:13
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    1,060 USD0SEC
    200 shares@ US$5.30Common StockSEC:0001455244-10-000093:0
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    4,928 USD0SEC
    928 shares@ US$5.31Common StockSEC:0001455244-10-000093:1
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    8,086 USD0SEC
    1,520 shares@ US$5.32Common StockSEC:0001455244-10-000093:2
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    3,738 USD0SEC
    700 shares@ US$5.34Common StockSEC:0001455244-10-000093:3
  • ▼
    SVP Clinical, Med. & Reg.; CMOExecutivesVaxart, Inc.
    1,072 USD0SEC
    200 shares@ US$5.36Common StockSEC:0001455244-10-000093:4

25 of 40 declarations